Insulin receptor substrate 1 may play divergent roles in human colorectal cancer development and progression

doi:10.3748/wjg.v26.i28.4140

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 26, Issue 28

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7591)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-4) series.

Item

Count

PDF

296

WORD

188

HTML

3053

Tables (1-4)

333

Sum=3870

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

431

Download

952

Sum=1383

Publishing Process of This Article

Item

Count

Browse

785

Download

1553

Sum=2338

Jul 28, 2020 (publication date) through Jan 21, 2025

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Jul 28, 2020; 26(28): 4140-4150
Published online Jul 28, 2020. doi: 10.3748/wjg.v26.i28.4140

Table 1 Analysis of correlation between insulin receptor substrate 1 expression and clinicopathologic features, n (%)

Clinicopathological features		IRS-1 expression		P Fisher exact test
Clinicopathological features		Weak (0), n = 66	Strong (1+, 2+), n = 61	P Fisher exact test
Age (yr)	≤ 60 (n = 42)	22 (33.8)	20 (33.3)	0.552
Age (yr)	> 60 (n = 83)	43 (66.2)	40 (66.7)	0.552
Gender	Male (n = 70)	37 (56.1)	33 (54.1)
Gender	Female (n = 56)	28 (42.4)	28 (45.9)
Tumor Localization	Rectum (n = 57)	33 (50.8)	24 (39.3)	0.134
Tumor Localization	Colon (n = 69)	32 (49.2)	37 (60.7)	0.134
Histological Type^a	A (n = 104)	46 (69.7)	58 (95.1)	< 0.001
Histological Type^a	MA (n = 23)	20 (30.3)	3 (4.9)	< 0.001
Histological differentiation^a	G2 (n = 87)	35 (53.8)	52 (85.2)	< 0.001
Histological differentiation^a	G3 (n = 39)	30 (46.2)	9 (14.8)	< 0.001
Tumor size	pT1 + pT2 (n = 11)	7 (10.6)	4 (6.6)	0.312
Tumor size	pT3 + pT4 (n = 116)	59 (89.4)	57 (93.4)	0.312
Lymph node Involvement	Negative (n = 60)	29 (43.9)	31 (50.8)	0.438
Lymph node Involvement	Positive (n = 67)	37 (56.1)	30 (49.2)	0.438

Correlations were analyzed by Fisher exact test.

^aP < 0.05; n: Number of cases; r: Correlation coefficient; A: Adenocarcinoma; MA: Mucinous adenocarcinoma; G2: Moderately differentiated; G3: Poorly differentiated; N (-): Negative lymph node invasion; N (+): Positive lymph node invasion.

Table 2 Analysis of correlations between Insulin receptor substrate 1, Bax and Bcl-xL expressions in primary colorectal cancer

Groups of patients			IRS-1–Bax			IRS-1–Bcl-xL
Groups of patients		n	P value	r	n	P value	r
All		123	< 0.001	0.513^a	119	< 0.001	0.354^a
Age (yr)	≤ 60	40	< 0.001	0.661^a	41	0.001	0.481^a
Age (yr)	> 60	81	< 0.001	0.424^a	76	0.020	0.267^a
Sex	Male	67	< 0.001	0.497^a	63	0.011	0.319^a
Sex	Female	55	< 0.001	0.537^a	55	0.002	0.415^a
Localization	Rectum	54	< 0.001	0.460^a	51	0.080	0.247^a
Localization	Colon	68	< 0.001	0.536^a	67	< 0.001	0.446^a
HP–type	A	101	< 0.001	0.535^a	96	< 0.001	0.535^a
HP–type	MA	22	0.953	-0.013	23	0.841	-0.044
G	G2	84	< 0.001	0.523^a	83	0.006	0.300^a
G	G3	38	0.263	0.186	35	0.474	0.125
T	pT1 + pT2	10	0.455	0.268	11	0.005	0.772^a
T	pT3 + pT4	113	< 0.001	0.529^a	108	0.001	0.302^a
N	pN (-)	58	< 0.001	0.507^a	57	0.007	0.351^a
N	pN (+)	65	< 0.001	0.493^a	62	0.007	0.336^a

Associations analyzed by Spearman's correlation rank test.

Table 3 Analysis of correlations between Insulin receptor substrate 1 and Ki-67 expression in primary colorectal cancer

Groups of patients			IRS-1 – Ki-67
Groups of patients		n	P value	r
All		102	0.589	0.054
Age (yr)	≤ 60	32	0.291	-0.193
Age (yr)	> 60	68	0.147	0.178
Sex	Male	55	0.893	0.018
Sex	Female	46	0.517	0.098
Localization	Rectum	45	0.662	-0.067
Localization	Colon	56	0.285	0.145
HP–type	A	85	0.751	0.035
HP–type	MA	17	0.239	-0.302
G	G2	71	0.845	0.024
G	G3	30	0.714	0.070
T	pT1 + pT2	8	0.043	0.723^a
T	pT3 + pT4	94	0.973	-0.004
N	pN (-)	49	0.471	0.105
N	pN (+)	53	0.999	0.000

Associations were analyzed by Spearman's correlation rank test.

Table 4 Analysis of correlations between Bax and Bcl-xL expression in primary colorectal cancer

Groups of patients			Bax–Bcl-xL
Groups of patients		n	P value	r
All		115	< 0.001	0.556^a
Age(yr)	≤ 60	39	< 0.001	0.575^a
Age(yr)	> 60	74	< 0.001	0.530^a
Sex	Male	60	< 0.001	0.453^a
Sex	Female	54	< 0.001	0.643^a
Localization	Rectum	48	< 0.001	0.490^a
Localization	Colon	66	< 0.001	0.594^a
HP–type	A	93	< 0.001	0.546^a
HP–type	MA	22	0.013	0.519^a
G	G2	80	< 0.001	0.523^a
G	G3	34	< 0.001	0.543^a
T	pT1 + pT2	10	0.537	0.222
T	pT3 + pT4	105	< 0.001	0.577^a
N	pN (-)	55	< 0.001	0.509^a
N	pN (+)	60	< 0.001	0.582^a

Associations were analyzed by Spearman's correlation rank test.

Citation: Lomperta K, Jakubowska K, Grudzinska M, Kanczuga-Koda L, Wincewicz A, Surmacz E, Sulkowski S, Koda M. Insulin receptor substrate 1 may play divergent roles in human colorectal cancer development and progression. World J Gastroenterol 2020; 26(28): 4140-4150
URL: https://www.wjgnet.com/1007-9327/full/v26/i28/4140.htm
DOI: https://dx.doi.org/10.3748/wjg.v26.i28.4140